Deep science investor Lindy Fishburne cofounded the seed- and early-stage venture firm Breakout Ventures several years ago, after cofounding Breakout Labs within the...
AltPep, a Seattle-based biotech startup tackling amyloid protein disorders, has raised $23.1 million in a Series A funding round.
The venture spun out the...
Machine-learning algorithms analyzing human communication can predict whether someone will develop Alzheimer’s disease more accurately than standard biomedical screening, say IBM and Pfizer....
The causes of aging are extremely complex and unclear. But with longevity clinical trials increasing, more answers—and questions—are emerging than ever before.
With the...